of breath. A chest CT scan showed a foreign body in the right middle lobe bronchus and same high density area along the bronchial wall. Bronchoscopy revealed similar bronchial injury and the biopsy tissue of bronchial mucosa demonstrated extensive inflammation, necrosis, and diffuse permeation by golden-brown fibrillary structures that stained positive for iron.
Background and Aims: Nowadays, there has been an increasing interest in the use of ultrasound for the evaluation of chest diseases especially in examining pleural effusions and sonographic appearances are helpful in determining the nature of pleural effusion. It will allow to diagnose a variety of thoracic disorders at the point of care and avoid waiting time to do therapeutic management right away, like inserting chest catheter/tube or do VATS and minimize costing for unnecessary tests in the analysis of the pleural fluid. In this context, the utility of sonographic appearances alone in the diagnosis of pleural effusion is now being well documented by using the Light's criteria as the reference standard.
Methods: Retrospective, Cross Sectional study Presence of each of the sonographic features will be given a score of 1: homogenously echogenic, echo floaters, fibrin strands, thickened pleura, consolidation, loculations, unilateral effusion.
Results:
We have a total of 135 subjects and 76 have exudative effusion based on Lights criteria. Different cross tabulations were conducted to determine the accuracy of sonographic scoring index and a score of >3 points (42 subjects under exudative effusion) yielded the most acceptable results significant at 0.005 (P = 0.003) with sensitivity of 55.3%, specificity of 71.2%.
Conclusion:
Based on the results of the study, the sonographic scoring system is a fair test to diagnose exudative effusion. But if this test will be used, based on the coordinates of the curve, the cutoff value should be lowered to 2.5 to 3 to have a sensitivity of 55.3% and a specificity of 71.2%. Larger prospective studies are required in order to validate and improve present findings. Pulmonologist and Sonologist may work together at the same time when thoracentesis is to be done to yield better outcome. In recent decades, NIPPV also can be used to treat acute respiratory failure. Evidences show that NIPPV had great benefits in COPD acute exacerbation, ventilator weaning of COPD patients, cardiogenic pulmonary edema and immunocompromised patients. The surgical wound pain usually influences the cough and respiratory function of thoracic surgery patients. These poor cough function can increase the occurrence of pneumonia and atelectasis that will prolong the admission days and cost subsequently. Recent research had shown that application of NIPPV in thoracic surgery patients can reduce the complication of post-surgery and accelerate the recovery of lung function.
Methods: A retrospective study had included total 182 thoracic surgery patients during 2015-2018. Control group was 97 patients and NIPPV group was 85 patients. NIPPV via mouth piece was used twice for all thoracic surgery patients daily for 3 days. Each time is 20-30 min.
Results: The length of hospital stay of control and intervention group was 10.11 AE 6.32 days vs 8.60 AE 4.58 (P = 0.07) respectively. For the lung resection subgroup, the length of hospital stay of intervention was significantly shortened as compared to control group. (9.86 AE 6.48 days vs 7.45 AE 3.36 days, P = 0.01) The percentage of post operation bronchoscopy intervention was also significantly decreased from 7.37% to 1.15% (P = 0.03) after NIPPV application.
Conclusion: NIPPV via mouth piece is a comfortable and simple method to provide lung expansion therapy. Post operation NIPPV intervention can significantly shorten the length of stay in lung resection patients and decease the use the bronchoscope for airway toilet. 
